Health insurance provider The Cigna Group will pay more than $172 million over claims it gave the federal government inaccurate Medicare Advantage diagnoses codes in order to inflate reimbursement.
The case centered around allegations that Cigna violated the False Claims Act by submitting and not withdrawing “inaccurate and untruthful” codes, according to the U.S. Department of Justice.
The department said in a statement Saturday that Cigna falsely certified in writing that its data was truthful. Cigna said that the settlement with the government resolved a long-running legal case and “avoided the uncertainty and further expense” of a drawn-out legal battle. Medicare Advantage plans are privately run versions of the federal government’s Medicare program mainly for people 65 and older.
Cigna also said it will enter a corporate-integrity agreement for five years with the Department of Health and Human Services inspector general office. That deal is designed to promote compliance with federal health program requirements.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. to rein in technology that limits Medicare Advantage carePatients noticed that one tool often predicted a patient’s date of discharge that coincided with the date their insurer cut off coverage.
Read more »
Big Health Insurers Expand Medicare Advantage To Even More Markets For 2024 CoverageCigna, CVS Health’s Aetna, Elevance Health, Humana and UnitedHealth Group are launching new Medicare Advantage plans in scores of new counties for 2024.
Read more »
Two Scripps Health groups are dropping Medicare Advantage plans in 2024Starting Jan. 1., two Scripps Health groups will no longer accept Medicare Advantage plans — a decision that will affect thousands of patients.
Read more »
FanDuel Promo Code: Sportsbook & Casino PromosClaim your FanDuel Promo Code to take advantage of this new customer offer.
Read more »
Lawsuits To Block Medicare Drug Price Negotiations Are Very Unpopular Among VotersThe IRA’s drug pricing provisions are viewed favorably by voters. Accordingly, the industry’s legal challenge to block Medicare from price negotiations is unpopular.
Read more »